| Avinza Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Avinza 120 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Avinza 60 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Avinza 30 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
| Avinza 90 mg/24 hours | capsule, extended release | oral | 1.0 each | OTC |
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2007 ... - Business Wire (press release)
The Company sold its commercial oncology products in October 2006 and sold its AVINZA® product line in February 2007. The results of operations related to ...
Wed Feb 20 16:14:49 -0500 2008
Ligand Pharma Q4 Profit Falls Despite Revenue Growth -Update - Trading Markets (press release)
The company sold its commercial oncology products in October last year and its Avinza product line in February 2007. Total revenues from continuing ...
Wed Feb 20 22:10:36 -0500 2008
Ligand Pharmaceuticals shares slide on 4Q results - CNNMoney.com
In 2008, Ligand said it expects to receive roughly $20 million in royalty revenue from King Pharmaceuticals (NYSE:KG) for sales of Avinza and potential ...
Thu Feb 21 14:56:27 -0500 2008
morphine sulfate